Northern Trust Corp Intellia Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 866,290 shares of NTLA stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
866,290
Previous 835,351 3.7%
Holding current value
$13.1 Million
Previous $18.7 Million 4.78%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$19.72 - $27.36 $610,117 - $846,491
30,939 Added 3.7%
866,290 $17.8 Million
Q2 2024

Aug 14, 2024
SELL
$20.02 - $27.22 $719,598 - $978,395
-35,944 Reduced 4.13%
835,351 $18.7 Million
Q1 2024

May 14, 2024
SELL
$23.82 - $32.8 $359,515 - $495,050
-15,093 Reduced 1.7%
871,295 $24 Million
Q4 2023

Feb 13, 2024
SELL
$23.16 - $32.34 $787,416 - $1.1 Million
-33,999 Reduced 3.69%
886,388 $27 Million
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $58,971 - $85,379
1,865 Added 0.2%
920,387 $29.1 Million
Q2 2023

Aug 11, 2023
BUY
$34.58 - $46.03 $5.43 Million - $7.23 Million
157,032 Added 20.62%
918,522 $37.5 Million
Q1 2023

May 15, 2023
SELL
$33.3 - $44.82 $278,721 - $375,143
-8,370 Reduced 1.09%
761,490 $28.4 Million
Q4 2022

Feb 13, 2023
BUY
$33.21 - $62.69 $2.16 Million - $4.08 Million
65,086 Added 9.24%
769,860 $26.9 Million
Q3 2022

Nov 14, 2022
BUY
$53.92 - $71.7 $38,660 - $51,408
717 Added 0.1%
704,774 $39.4 Million
Q2 2022

Aug 12, 2022
BUY
$38.49 - $76.21 $556,026 - $1.1 Million
14,446 Added 2.09%
704,057 $36.4 Million
Q1 2022

May 13, 2022
SELL
$58.27 - $118.99 $2.81 Million - $5.73 Million
-48,192 Reduced 6.53%
689,611 $50.1 Million
Q4 2021

Feb 08, 2022
SELL
$100.76 - $138.36 $595,995 - $818,399
-5,915 Reduced 0.8%
737,803 $87.2 Million
Q3 2021

Nov 15, 2021
BUY
$132.37 - $176.78 $4.82 Million - $6.44 Million
36,421 Added 5.15%
743,718 $99.8 Million
Q2 2021

Aug 13, 2021
BUY
$60.88 - $161.91 $3.8 Million - $10.1 Million
62,476 Added 9.69%
707,297 $115 Million
Q1 2021

May 12, 2021
BUY
$46.59 - $83.68 $135,763 - $243,843
2,914 Added 0.45%
644,821 $51.8 Million
Q4 2020

Feb 11, 2021
SELL
$18.83 - $63.53 $178,884 - $603,535
-9,500 Reduced 1.46%
641,907 $34.9 Million
Q3 2020

Nov 16, 2020
BUY
$17.47 - $24.93 $3.14 Million - $4.48 Million
179,775 Added 38.12%
651,407 $13 Million
Q2 2020

Aug 14, 2020
SELL
$11.14 - $22.87 $437,345 - $897,853
-39,259 Reduced 7.68%
471,632 $9.91 Million
Q1 2020

May 14, 2020
BUY
$9.44 - $15.58 $80,060 - $132,133
8,481 Added 1.69%
510,891 $6.25 Million
Q4 2019

Feb 14, 2020
BUY
$10.43 - $17.67 $115,939 - $196,419
11,116 Added 2.26%
502,410 $7.37 Million
Q3 2019

Nov 13, 2019
BUY
$13.07 - $18.51 $1.09 Million - $1.54 Million
83,346 Added 20.43%
491,294 $6.56 Million
Q2 2019

Aug 13, 2019
BUY
$13.88 - $18.41 $190,669 - $252,898
13,737 Added 3.48%
407,948 $6.68 Million
Q1 2019

May 13, 2019
BUY
$12.79 - $17.62 $54,753 - $75,431
4,281 Added 1.1%
394,211 $6.73 Million
Q4 2018

Feb 12, 2019
SELL
$11.39 - $27.13 $43,726 - $104,152
-3,839 Reduced 0.97%
389,930 $5.32 Million
Q3 2018

Nov 14, 2018
BUY
$25.78 - $32.6 $763,036 - $964,894
29,598 Added 8.13%
393,769 $11.3 Million
Q2 2018

Sep 18, 2018
SELL
$20.02 - $30.79 $50,090 - $77,036
-2,502 Reduced 0.68%
364,171 $9.96 Million
Q2 2018

Aug 14, 2018
BUY
$20.02 - $30.79 $3.64 Million - $5.61 Million
182,055 Added 98.61%
366,673 $10 Million
Q1 2018

May 09, 2018
BUY
$19.43 - $34.95 $34,624 - $62,280
1,782 Added 0.97%
184,618 $3.89 Million
Q4 2017

Feb 14, 2018
BUY
$17.39 - $31.12 $533,473 - $954,668
30,677 Added 20.16%
182,836 $3.51 Million
Q3 2017

Nov 13, 2017
BUY
$15.16 - $25.75 $2.31 Million - $3.92 Million
152,159
152,159 $3.78 Million

Others Institutions Holding NTLA

# of Institutions
312
Shares Held
91.4M
Call Options Held
417K
Put Options Held
824K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.15B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email